Biotechnology
Compare Stocks
2 / 10Stock Comparison
ALMS vs VTRS
Revenue, margins, valuation, and 5-year total return — side by side.
Drug Manufacturers - Specialty & Generic
ALMS vs VTRS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Biotechnology | Drug Manufacturers - Specialty & Generic |
| Market Cap | $2.79B | $20.25B |
| Revenue (TTM) | $22M | $14.56B |
| Net Income (TTM) | $-245M | $-296M |
| Gross Margin | 96.3% | 34.4% |
| Operating Margin | -20.6% | 1.0% |
| Forward P/E | — | 7.1x |
| Total Debt | $37M | $14.70B |
| Cash & Equiv. | $90M | $1.35B |
ALMS vs VTRS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 24 | May 26 | Return |
|---|---|---|---|
| Alumis Inc. Common … (ALMS) | 100 | 178.6 | +78.6% |
| Viatris Inc. (VTRS) | 100 | 163.6 | +63.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ALMS vs VTRS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ALMS is the clearest fit if your priority is growth exposure and long-term compounding.
- EPS growth 72.4%
- 78.6% 10Y total return vs VTRS's -51.5%
- Lower volatility, beta 1.77, Low D/E 12.3%, current ratio 4.34x
VTRS carries the broadest edge in this set and is the clearest fit for income & stability and defensive.
- Dividend streak 0 yrs, beta 0.99, yield 2.8%
- Beta 0.99, yield 2.8%, current ratio 1.30x
- -2.0% margin vs ALMS's -11.1%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -2.5% revenue growth vs VTRS's -3.0% | |
| Quality / Margins | -2.0% margin vs ALMS's -11.1% | |
| Stability / Safety | Beta 0.99 vs ALMS's 1.77 | |
| Dividends | 2.8% yield; the other pay no meaningful dividend | |
| Momentum (1Y) | +396.0% vs VTRS's +107.8% | |
| Efficiency (ROA) | -0.8% ROA vs ALMS's -57.6%, ROIC -6.6% vs -184.1% |
ALMS vs VTRS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
ALMS vs VTRS — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
VTRS leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
VTRS is the larger business by revenue, generating $14.6B annually — 658.3x ALMS's $22M. VTRS is the more profitable business, keeping -2.0% of every revenue dollar as net income compared to ALMS's -11.1%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $22M | $14.6B |
| EBITDAEarnings before interest/tax | -$453M | $2.3B |
| Net IncomeAfter-tax profit | -$245M | -$296M |
| Free Cash FlowCash after capex | -$373M | $1.7B |
| Gross MarginGross profit ÷ Revenue | +96.3% | +34.4% |
| Operating MarginEBIT ÷ Revenue | -20.6% | +1.0% |
| Net MarginNet income ÷ Revenue | -11.1% | -2.0% |
| FCF MarginFCF ÷ Revenue | -16.9% | +11.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | +8.1% |
| EPS Growth (YoY)Latest quarter vs prior year | +38.7% | +105.9% |
Valuation Metrics
VTRS leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $2.8B | $20.2B |
| Enterprise ValueMkt cap + debt − cash | $2.7B | $33.6B |
| Trailing P/EPrice ÷ TTM EPS | -8.31x | -5.80x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 7.12x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 248.54x |
| Price / SalesMarket cap ÷ Revenue | 116.09x | 1.42x |
| Price / BookPrice ÷ Book value/share | 67.05x | 1.38x |
| Price / FCFMarket cap ÷ FCF | — | 10.45x |
Profitability & Efficiency
VTRS leads this category, winning 5 of 8 comparable metrics.
Profitability & Efficiency
VTRS delivers a -2.0% return on equity — every $100 of shareholder capital generates $-2 in annual profit, vs $-76 for ALMS. ALMS carries lower financial leverage with a 0.12x debt-to-equity ratio, signaling a more conservative balance sheet compared to VTRS's 1.00x. On the Piotroski fundamental quality scale (0–9), VTRS scores 4/9 vs ALMS's 3/9, reflecting mixed financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -75.5% | -2.0% |
| ROA (TTM)Return on assets | -57.6% | -0.8% |
| ROICReturn on invested capital | -184.1% | -6.6% |
| ROCEReturn on capital employed | -144.4% | -8.1% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 4 |
| Debt / EquityFinancial leverage | 0.12x | 1.00x |
| Net DebtTotal debt minus cash | -$53M | $13.4B |
| Cash & Equiv.Liquid assets | $90M | $1.3B |
| Total DebtShort + long-term debt | $37M | $14.7B |
| Interest CoverageEBIT ÷ Interest expense | — | -0.51x |
Total Returns (Dividends Reinvested)
ALMS leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ALMS five years ago would be worth $17,865 today (with dividends reinvested), compared to $14,034 for VTRS. Over the past 12 months, ALMS leads with a +396.0% total return vs VTRS's +107.8%. The 3-year compound annual growth rate (CAGR) favors VTRS at 24.2% vs ALMS's 21.3% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +165.3% | +40.5% |
| 1-Year ReturnPast 12 months | +396.0% | +107.8% |
| 3-Year ReturnCumulative with dividends | +78.6% | +91.8% |
| 5-Year ReturnCumulative with dividends | +78.6% | +40.3% |
| 10-Year ReturnCumulative with dividends | +78.6% | -51.5% |
| CAGR (3Y)Annualised 3-year return | +21.3% | +24.2% |
Risk & Volatility
VTRS leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
VTRS is the less volatile stock with a 0.99 beta — it tends to amplify market swings less than ALMS's 1.77 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. VTRS currently trades 99.7% from its 52-week high vs ALMS's 77.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.77x | 0.99x |
| 52-Week HighHighest price in past year | $30.60 | $17.45 |
| 52-Week LowLowest price in past year | $2.76 | $8.19 |
| % of 52W HighCurrent price vs 52-week peak | +77.6% | +99.7% |
| RSI (14)Momentum oscillator 0–100 | 54.3 | 75.7 |
| Avg Volume (50D)Average daily shares traded | 1.4M | 10.6M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates ALMS as "Buy" and VTRS as "Hold". Consensus price targets imply 61.8% upside for ALMS (target: $38) vs -12.3% for VTRS (target: $15). VTRS is the only dividend payer here at 2.76% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold |
| Price TargetConsensus 12-month target | $38.44 | $15.25 |
| # AnalystsCovering analysts | 8 | 12 |
| Dividend YieldAnnual dividend ÷ price | — | +2.8% |
| Dividend StreakConsecutive years of raises | — | 0 |
| Dividend / ShareAnnual DPS | — | $0.48 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +2.5% |
VTRS leads in 4 of 6 categories (Income & Cash Flow, Valuation Metrics). ALMS leads in 1 (Total Returns).
ALMS vs VTRS: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is ALMS or VTRS a better buy right now?
Analysts rate Alumis Inc.
Common Stock (ALMS) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — ALMS or VTRS?
Over the past 5 years, Alumis Inc.
Common Stock (ALMS) delivered a total return of +78. 6%, compared to +40. 3% for Viatris Inc. (VTRS). Over 10 years, the gap is even starker: ALMS returned +78. 6% versus VTRS's -51. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — ALMS or VTRS?
By beta (market sensitivity over 5 years), Viatris Inc.
(VTRS) is the lower-risk stock at 0. 99β versus Alumis Inc. Common Stock's 1. 77β — meaning ALMS is approximately 78% more volatile than VTRS relative to the S&P 500. On balance sheet safety, Alumis Inc. Common Stock (ALMS) carries a lower debt/equity ratio of 12% versus 100% for Viatris Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — ALMS or VTRS?
On earnings-per-share growth, the picture is similar: Alumis Inc.
Common Stock grew EPS 72. 4% year-over-year, compared to -466. 0% for Viatris Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — ALMS or VTRS?
Viatris Inc.
(VTRS) is the more profitable company, earning -24. 6% net margin versus -1011. 7% for Alumis Inc. Common Stock — meaning it keeps -24. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VTRS leads at -18. 6% versus -1886. 9% for ALMS. At the gross margin level — before operating expenses — ALMS leads at 96. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is ALMS or VTRS more undervalued right now?
Analyst consensus price targets imply the most upside for ALMS: 61.
8% to $38. 44.
07Which pays a better dividend — ALMS or VTRS?
In this comparison, VTRS (2.
8% yield) pays a dividend. ALMS does not pay a meaningful dividend and should not be held primarily for income.
08Is ALMS or VTRS better for a retirement portfolio?
For long-horizon retirement investors, Viatris Inc.
(VTRS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 99), 2. 8% yield). Alumis Inc. Common Stock (ALMS) carries a higher beta of 1. 77 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (VTRS: -51. 5%, ALMS: +78. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between ALMS and VTRS?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
VTRS pays a dividend while ALMS does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.